Gainers

• EUDA Health Holdings (NASDAQ:EUDA) stock rose 127.5% to $13.74 during Thursday's regular session. The market value of their outstanding shares is at $15.1 million.
• Cumberland Pharma (NASDAQ:CPIX) stock moved upwards by 23.6% to $3.77. The market value of their outstanding shares is at $45.6 million.
• NewcelX (NASDAQ:NCEL) stock rose 22.4% to $4.48. The market value of their outstanding shares is at $18.4 million.
• Replimune Group (NASDAQ:REPL) shares rose 18.72% to $2.69. The company's market cap stands at $178.0 million.
• cbdMD (AMEX:YCBD) stock moved upwards by 16.66% to $1.08. The company's market cap stands at $9.7 million.
• Citius Pharmaceuticals (NASDAQ:CTXR) stock moved upwards by 15.94% to $1.0. The market value of their outstanding shares is at $19.2 million.

Losers

• SILO Pharma (NASDAQ:SILO) shares fell 25.4% to $0.43 during Thursday's regular session. The company's market cap stands at $9.2 million.
• Medpace Holdings (NASDAQ:MEDP) shares decreased by 22.98% to $391.63. The market value of their outstanding shares is at $14.4 billion. As per the press release, Q1 earnings came out yesterday.
• Alpha Compute (NASDAQ:ALP) stock fell 21.48% to $0.18. The company's market cap stands at $5.3 million.
• Icecure Medical (NASDAQ:ICCM) shares fell 18.84% to $0.29. The market value of their outstanding shares is at $29.0 million.
• Altimmune (NASDAQ:ALT) stock fell 18.13% to $2.84. The company's market cap stands at $451.4 million.
• Axe Compute (NASDAQ:AGPU) stock fell 17.61% to $7.21. The market value of their outstanding shares is at $29.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.